Načítá se...
Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis
Visceral leishmaniasis (VL) is a tropical infectious disease, which is called Mediterranean visceral leishmaniasis (MVL) in the Mediterranean area. In spite of many attempts, no effective commercial vaccine exists for MVL. To find new targets for developing antileishmanial vaccines, knowing parasite...
Uloženo v:
| Vydáno v: | J Parasit Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer India
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5962495/ https://ncbi.nlm.nih.gov/pubmed/29844618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-018-0986-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|